Single-Photon Emission Computed Tomography (SPECT) Market Statistics, Emerging Trends, Key Drivers And Forecast To 2033

The single-photon emission computed tomography (spect) market size has grown strongly in recent years. It will grow from $2.27 billion in 2023 to $2.43 billion in 2024 at a compound annual growth rate (CAGR) of 7.1%. The growth in the historic period can be attributed to growing diagnostic imaging needs, rising incidence of chronic diseases, advancements in radiopharmaceuticals, expanding aging population, increasing healthcare expenditure..

The single-photon emission computed tomography (spect) market size is expected to see strong growth in the next few years. It will grow to $3.3 billion in 2028 at a compound annual growth rate (CAGR) of 7.9%. The growth in the forecast period can be attributed to growing emphasis on precision medicine, expanding applications in neurological imaging, global rise in cancer incidence, advancements in radiotracer development, integration into multimodal imaging systems.. Major trends in the forecast period include enhanced image reconstruction techniques, mobile spect imaging services, growing emphasis on cardiac imaging, innovations in detector technology, increasing clinical research initiatives..

Market Overview -
Single-photon emission computed tomography (SPECT) is a medical imaging technique that uses radioactive tracers and gamma rays to produce 3D images of internal organs and tissues. The tracer can be detected by a gamma camera by emitting gamma rays, allowing for non-invasive and detailed imaging of a patient's internal structure.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=9960&type=smp

Rising Cancer Prevalence Driving The Single-Photon Emission Computed Tomography (SPECT) Market
The rise in the prevalence of cases of cancer is expected to propel the growth of the single-photon emission computed tomography (SPECT) market going forward. This rise in the number of cancer cases has resulted from a rise in the aging population, unhealthy lifestyle choices, and environmental factors. Single-photon emission computed tomography (SPECT) helps in the diagnosis, staging, and monitoring of cancer along with other imaging techniques like computed tomography (CT) and Magnetic Resonance Imaging (MRI) scans. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million deaths, which is 74% of those caused by non-communicable diseases (NCDs) or chronic diseases every year globally. There were 17.9 million deaths from cardiovascular diseases, 9.3 million deaths from cancer, 4.1 million deaths from chronic respiratory diseases, and 2.0 million deaths from diabetes. . Therefore, the rise in the prevalence of cases of cancer is driving the growth of the single-photon emission computed tomography (SPECT) market.

Competitive Landscape -
Major companies operating in the single-photon emission computed tomography (spect) market report are GE Healthcare Technologies Inc., Siemens AG, Bruker Corporation, Digirad Corporation, Mediso Ltd., DDD-Diagnostic A/S, Bracco Diagnostic SpA, Cardinal Health Inc., Curium Pharma UK Ltd., Spectrum Dynamics Medical Inc., Koninklijke Philips N.V., Beijing Hamamatsu Photon Techniques Inc., Novartis AG, MIE Medical Imaging Electronics GmbH, Global Medical Solutions Private Limited, Canon Medical Systems Corporation, Esaote S.p.A., Invicro LLC, LambdaSpect Ltd., Mediso Medical Imaging Systems Ltd., MR Solutions Ltd., TriFoil Imaging Inc., Gamma Medica Inc., Guerbet SA, Lantheus Medical Imaging Inc., Neusoft Medical Systems Co. Ltd., NTP Radioisotopes SOC Ltd., SurgicEye GmbH, Cubresa Inc., NeuroLogica Corp. .

Revolutionizing Imaging With Advancements Reshaping The Single-Photon Emission Computed Tomography (SPECT) Market
Technological advancements are a key trend gaining popularity in the single-photon emission computed tomography (SPECT) market. Companies operating in the single-photon emission computed tomography (SPECT) market are adopting new technologies like high-resolution imaging to sustain their position in the market. For instance, in June 2022, Siemens Healthcare, a Germany-based medical device and medical solution manufacturing company, launched the Symbia Pro. Spectra SPECT/CT Scanner. This Symbia Pro. Spectra SPECT/CT device has advanced imaging technology, improved accessibility, optimal low-dose imaging, automated SPECT motion correction, and customized clinical tools designed for imaging in cardiology, oncology, orthopedics, and neurology applications. This device also has the myExam Companion feature, which enables automated workflow guidance.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/single-photon-emission-computed-tomography-spect-global-market-report

Key Segments -

The single-photon emission computed tomography (spect) market covered in this report is segmented -

1) By Type: Hybrid SPECT Systems, Standalone SPECT Systems
2) By Type Of Radioisotopes: Tc-99m, Ra-223, Ga-67, I-123, Other Radioisotopes
3) By Application: Oncology, Cardiology, Neurology, Other Applications
4) By End User: Hospitals, Diagnostic Centers, Other End User

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.